Patents by Inventor Brian Gary DREW

Brian Gary DREW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
    Patent number: 12221491
    Abstract: The specification relates generally to the post-genomic identification of therapeutic targets and agents. In particular the specification relates to PSMD9 inhibitors and methods for preventing or treating metabolic disorders such as fatty liver disease that are associated with dysregulation of lipid homeostasis.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: February 11, 2025
    Assignees: Baker Heart and Diabetes Institute, The University of Sydney
    Inventors: Anna Christine Drew, Brian Gary Drew, Thomas de Aguiar Vallim, David James
  • METHOD OF MODULATING ADIPOSITY
    Publication number: 20220282257
    Abstract: A method of modulating adiposity using PSMD9 inhibitors
    Type: Application
    Filed: August 19, 2020
    Publication date: September 8, 2022
    Inventors: Anna Christine DREW, Brian Gary DREW, Thomas de Aguiar VALLIM
  • MODULATORY AGENTS
    Publication number: 20210095048
    Abstract: The specification relates generally to the post-genomic identification of therapeutic targets and agents. In particular the specification relates to PSMD9 inhibitors and methods for preventing or treating metabolic disorders such as fatty liver disease that are associated with dysregulation of lipid homeostasis.
    Type: Application
    Filed: January 21, 2019
    Publication date: April 1, 2021
    Applicants: Baker Heart and Diabetes Institute, The Regents of the University of California, The University of Sydney
    Inventors: Anna Christine DREW, Brian Gary DREW, Thomas de Aguiar VALLIM, David JAMES